Universal Ibogaine (TSXV:IBO) Total Liabilities : C$3.85 Mil (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Total Liabilities?

Universal Ibogaine's Total Liabilities for the quarter that ended in Jan. 2024 was C$3.85 Mil.

Universal Ibogaine's quarterly Total Liabilities increased from Jul. 2023 (C$3.75 Mil) to Oct. 2023 (C$3.87 Mil) but then declined from Oct. 2023 (C$3.87 Mil) to Jan. 2024 (C$3.85 Mil).

Universal Ibogaine's annual Total Liabilities increased from Mar. 2021 (C$2.20 Mil) to Jul. 2022 (C$2.38 Mil) and increased from Jul. 2022 (C$2.38 Mil) to Jul. 2023 (C$3.75 Mil).

Universal Ibogaine Total Liabilities Historical Data

The historical data trend for Universal Ibogaine's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Total Liabilities Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Total Liabilities

Get a 7-Day Free Trial

0.02

2.20

2.38

3.75

Universal Ibogaine Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Liabilities	Get a 7-Day Free Trial															3.36	3.68	3.75	3.87	3.85

Universal Ibogaine Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Universal Ibogaine's Total Liabilities for the fiscal year that ended in Jul. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.788	+	(0.962	+	2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.75

Total Liabilities	=	Total Assets (A: Jul. 2023 )	-	Total Equity (A: Jul. 2023 )
	=	5.502	-	1.752
	=	3.75

Universal Ibogaine's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.186	+	(2.666	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.85

Total Liabilities	=	Total Assets (Q: Jan. 2024 )	-	Total Equity (Q: Jan. 2024 )
	=	5.607	-	1.755
	=	3.85

Universal Ibogaine Total Liabilities Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine (TSXV:IBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines